Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
1.
J Infect Chemother ; 28(11): 1562-1566, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35931413

ABSTRACT

Anti-interferon (IFN)-γ autoantibody-positive syndrome is one of the acquired non-HIV cellular immunodeficiencies, caused by abnormalities in the IFN-γ/interleukin (IL)-12 pathways. It is often diagnosed alongside the onset of disseminated mycobacterium infection, and requires continuous antimycobacterial chemotherapy; however, the detailed pathological mechanisms underlying this syndrome, including its prognosis, are not known. To the best of our knowledge, this is the first reported case of intravascular large B-cell lymphoma complicated by anti-IFN-γ autoantibody syndrome, presented in an 82-year-old woman. The patient had been diagnosed with anti-IFN-γ autoantibody immunodeficiency ten years ago. She had repeated subacute fever of undetermined origin for 13 months that made us suspect infections, such as disseminated mycobacterium disease and other viral and fungal infections, despite receiving prophylactic antimycobacterial chemotherapy with rifampicin and clarithromycin. However, all the screenings performed showed no evidence of infectious diseases; thus, she was finally diagnosed with intravascular large B-cell lymphoma via a random skin biopsy. Unfortunately, the patient debilitated rapidly and died. Evidence supporting a correlation between anti-IFN-γ autoantibody syndrome and carcinogenesis is still lacking, although it is known that patients with anti-IFN-γ autoantibody syndrome are at risk of persistent viral infection-related and T-cell lineage-related carcinogenesis. This case demonstrated that patients with anti-IFN-γ autoantibody syndrome are also at risk of developing B-cell lymphoma, such as intravascular lymphoma. This emphasizes that caution should be paid to increased risk of developing malignancy during the long-term management of anti-IFN-γ autoantibody syndrome with cellular immunodeficiency.


Subject(s)
Immunologic Deficiency Syndromes , Lymphoma, B-Cell , Mycobacterium Infections, Nontuberculous , Aged, 80 and over , Anti-Bacterial Agents/therapeutic use , Autoantibodies/therapeutic use , Carcinogenesis , Female , Humans , Immunologic Deficiency Syndromes/complications , Interferon-gamma , Lymphoma, B-Cell/complications , Lymphoma, B-Cell/drug therapy , Mycobacterium Infections, Nontuberculous/drug therapy
2.
Surg Today ; 45(9): 1187-9, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25069423

ABSTRACT

A 61-year-old male was admitted to our hospital complaining of bloody sputum. A chest roentgenogram revealed a clearly demarcated mass located in the anterior mediastinum. Positron emission tomography revealed abnormal accumulation of (18)F-fluorodeoxy glucose only in the anterior mediastinal tumor. A computed tomography-guided needle aspiration biopsy was performed, and the tumor was diagnosed as a malignant melanoma. Although the skin, eyeballs, oral cavity, nasal cavity, etc., were closely evaluated, no other lesion of malignant melanoma was detected except the mediastinal tumor. Hence, this tumor was diagnosed as a primary malignant melanoma. We performed total thymectomy, including the tumor, and combined resection of the adhesive bilateral lungs, pericardium and left brachiocephalic vein. Because the tumor was histologically surrounded by thymus tissue, we diagnosed it as a primary mediastinal malignant melanoma that originated in the thymus. Although the patient's postoperative course was uneventful, he complained of back pain 5 months after the operation. Multiple bone metastases were found, and he received chemotherapy and radiotherapy, and is currently alive with disease 14 months after the primary treatment.


Subject(s)
Melanoma/diagnosis , Melanoma/surgery , Thymus Neoplasms/diagnosis , Thymus Neoplasms/surgery , Biopsy, Needle , Bone Neoplasms/secondary , Brachiocephalic Veins/surgery , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Male , Melanoma/pathology , Melanoma/secondary , Middle Aged , Pericardium/surgery , Pneumonectomy/methods , Positron-Emission Tomography , Radiopharmaceuticals , Thymectomy , Thymus Neoplasms/pathology , Treatment Outcome
3.
Respirol Case Rep ; 12(3): e01338, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38528947

ABSTRACT

We present the case of a patient who developed a massive right pleural effusion after pelvic surgery, not thoracic surgery. Lymphatic leakage into the abdominal cavity after pelvic surgery can cause massive pleural effusion when complicated with porous diaphragm syndrome.

4.
Thorac Cancer ; 15(1): 104-107, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38098256

ABSTRACT

IgG4-related diseases are adverse events that occur after receiving treatment with immune checkpoint inhibitors (ICI). This study reports the first case of IgG4-related retroperitoneal fibrosis after the administration of chemotherapy with nivolumab and ipilimumab (NI therapy). An 80-year-old man developed lower abdominal pain eight months after NI therapy was initiated. Although the primary lesion maintained its reduced size on computed tomography, there was an increase in the soft tissue shadows intensity around the abdominal aorta, bladder, and seminal vesicles, suggesting retroperitoneal fibrosis. Blood tests showed elevated IgG4 levels. Computed tomography-guided biopsy of the retroperitoneum showed B cell-dominant lymphocyte infiltration consistent with IgG4-related retroperitoneal fibrosis and characteristic CD8-positive lymphocyte infiltration, suggestive of the involvement of cytotoxic T cells. Based on the clinical, imaging, and pathological findings, the patient was diagnosed with IgG4-related retroperitoneal fibrosis due to ICI. Immunotherapy discontinuation alone did not result in improvement; therefore, steroid therapy was initiated. In clinical practice, IgG4-related retroperitoneal fibrosis can occur as an immune-related adverse event when administering anti-PD-1 and anti-CTLA-4 antibodies for cancer immunotherapy. Early steroid therapy could be effective in controlling this immune-related adverse event.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Retroperitoneal Fibrosis , Male , Humans , Aged, 80 and over , Retroperitoneal Fibrosis/chemically induced , Retroperitoneal Fibrosis/diagnosis , Retroperitoneal Fibrosis/drug therapy , Carcinoma, Non-Small-Cell Lung/drug therapy , Nivolumab/adverse effects , Ipilimumab/adverse effects , Immunoglobulin G , Lung Neoplasms/drug therapy , Steroids/therapeutic use
5.
Respir Med Case Rep ; 45: 101902, 2023.
Article in English | MEDLINE | ID: mdl-37538979

ABSTRACT

Bacillus Calmette-Guerin (BCG) intravesical injections are used as adjuvant therapy for superficial bladder cancer. We report a case of a 78-year-old man who developed disseminated M. bovis BCG disease mimicking miliary tuberculosis early after BCG intravesical infusion. He started coughing after receiving three rounds of BCG for superficial bladder tumors, following transurethral resection of the tumors, approximately one month after initiation. Computerized tomography (CT) images showed diffuse nodular shadows in the bilateral lung fields with a random pattern. Consequently, disseminated BCG disease was diagnosed. Treatment with isoniazid, rifampicin, and ethambutol was initiated. Nine months after initiating treatment, CT showed the disappearance of the miliary shadows. We also discussed 77 cases of suspected BCG infection and the requests for Mycobacterium bovis BCG identification at our institution from 2017 to October 2022. Of these, 76 cases were M. bovis BCG, and 1 case was M. tuberculosis. Since M. tuberculosis can be identified in some patients with suspected BCG infection, it is crucial to distinguish between the two based on pathogenicity.

6.
Case Rep Oncol ; 16(1): 1409-1414, 2023.
Article in English | MEDLINE | ID: mdl-38028574

ABSTRACT

Introduction: Diffuse lung cysts occur owing to several diseases; however, diffuse cystic lung metastases are very rare in the case of lung cancer. We report a rare case of diffuse cystic lung metastases from lung adenocarcinoma and reviewed previously reported cases of cystic lung metastases for lung cancer and determined their characteristics. Case Presentation: A 78-year-old Japanese woman with advanced lung adenocarcinoma was positive for the epidermal growth factor receptor gene mutation exon 21 L858R and had been treated with osimertinib. She presented with multiple bilaterally positioned thin-walled lung cysts and pneumothorax. Lung cysts were diagnosed as cystic lung metastases from lung cancer, and carboplatin, pemetrexed, and pembrolizumab were subsequently administered. All cysts markedly decreased in size, and some disappeared. Conclusion: Effective treatment methods for cystic lung metastases from lung cancer have not been reported. To our knowledge, this is the first case of cystic lung metastases that were successfully treated with chemotherapy.

7.
Egypt J Intern Med ; 35(1): 13, 2023.
Article in English | MEDLINE | ID: mdl-36785595

ABSTRACT

Background: Coronavirus disease 2019 (COVID-19) was previously thought to have a low reinfection rate, but there are concerns that the reinfection rate will increase with the emergence and spread of mutant variants. This report describes the case of a 36-year-old, non-immunosuppressed man who was infected twice by two different variants of COVID-19 within a relatively short period. Case presentation: A 36-year-old Japanese man with no comorbidities was infected with the E484K variant (R.1 lineage) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms were mild and improved with symptomatic treatment alone. About four months later he presented to another outpatient department with high fever and headache. We diagnosed him as infected with the Alpha variant (B.1.1.7) of SARS-CoV-2 based on SARS-CoV-2 real-time reverse transcription polymerase chain reaction testing (RT-PCR). The patient was hospitalized with high fever. The patient received treatment in the form of anti-inflammatory therapy with corticosteroid and antibacterial chemotherapy. The patient improved without developing severe disease. Conclusion: Concerns have been raised that the reinfection rate of COVID-19 will increase with the emergence of mutant variants. Particularly in mild cases, adequate amounts of neutralizing antibodies may not be produced, and reinfection may thus occur. Continued attention to sufficient infection control is thus essential.

8.
Sci Rep ; 13(1): 7858, 2023 05 15.
Article in English | MEDLINE | ID: mdl-37188839

ABSTRACT

Distinguishing between nontuberculous mycobacterial pulmonary disease (NTM-PD) and pulmonary tuberculosis (TB) is difficult. We aimed to evaluate the usefulness of gastric aspirate examination for NTM-PD diagnosis and for differentiating NTM-PD from other diseases, including pulmonary TB. We retrospectively collected data for 491 patients with negative sputum smears or a lack of sputum production at Fukujuji Hospital. We compared 31 patients with NTM-PD to 218 patients with other diseases (excluding 203 with pulmonary TB). Additionally, we compared 81 patients with NTM cultured from at least one sputum or bronchoscopy sample to the other 410 patients. Gastric aspirate examination for NTM-PD diagnosis showed 74.2% sensitivity and 99.0% specificity for culture positivity. There was no significant difference between the nodular bronchiectatic disease and cavitary disease types for culture positivity (p = 0.515). The significance of NTM isolation from gastric aspirate showed 64.2% sensitivity and 99.8% specificity for culture positivity. Gastric aspirate examination revealed NTM in one TB patient, allowing TB to be ruled out in 98.1% of patients with NTM cultured from gastric aspirates. Gastric aspirate examination is helpful for early-stage NTM diagnosis and ruling out pulmonary TB. This could lead to more accurate and timely treatment.


Subject(s)
Bronchiectasis , Mycobacterium Infections, Nontuberculous , Tuberculosis, Pulmonary , Humans , Retrospective Studies , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/microbiology , Lung
9.
Intern Med ; 62(6): 871-875, 2023 Mar 15.
Article in English | MEDLINE | ID: mdl-35945007

ABSTRACT

Common variable immunodeficiency (CVID) causes granulomatous-lymphocytic interstitial lung disease (GLILD) and has a poor prognosis. We herein report a case of GLILD in a 49-year-old woman with CTLA-4 deficiency-associated CVID. The patient presented with dyspnea that had worsened over the past two years. A laboratory examination revealed hypoglobulinemia and pancytopenia. Chest computed tomography showed diffuse infiltrative and granular shadows in the bilateral interstitium. A flow cytometric analysis of blood cells and genetic testing confirmed CTLA-4 deficiency. We performed video-assisted thoracoscopic surgery for the pathological diagnosis of GLILD and to exclude infection and malignancy. Corticosteroid treatment successfully improved the condition of the patient.


Subject(s)
Common Variable Immunodeficiency , Lung Diseases, Interstitial , Female , Humans , Middle Aged , Lung Diseases, Interstitial/complications , Lung Diseases, Interstitial/diagnostic imaging , Lung Diseases, Interstitial/drug therapy , CTLA-4 Antigen , Granuloma/diagnosis , Common Variable Immunodeficiency/complications , Common Variable Immunodeficiency/drug therapy , Common Variable Immunodeficiency/diagnosis , Tomography, X-Ray Computed/adverse effects
10.
PLoS One ; 17(5): e0267566, 2022.
Article in English | MEDLINE | ID: mdl-35594509

ABSTRACT

BACKGROUND: To control COVID-19 pandemic is of critical importance to the global public health. To capture the prevalence in an accurate and timely manner and to understand the mode of nosocomial infection are essential for its preventive measure. METHODS: We recruited 685 healthcare workers (HCW's) at Tokyo Shinagawa Hospital prior to the vaccination with COVID-19 vaccine. Sera of the subjects were tested by assays for the titer of IgG against S protein's receptor binding domain (IgG (RBD)) or IgG against nucleocapsid protein (IgG (N)) of SARS-CoV-2. Together with PCR data, the positive rates by these methods were evaluated. RESULTS: Overall positive rates among HCW's by PCR, IgG (RBD), IgG (N) with a cut-off of 1.4 S/C (IgG (N)1.4), and IgG (N) with a cut-off of 0.2 S/C (IgG (N)0.2) were 3.5%, 9.5%, 6.1%, and 27.7%, respectively. Positive rates of HCW's working in COVID-19 ward were significantly higher than those of HCW's working in non-COVID-19 ward by all the four methods. Concordances of IgG (RBD), IgG (N)1.4, and IgG (N)0.2 against PCR were 97.1%, 71.4%, and 88.6%, respectively. By subtracting the positive rates of PCR from that of IgG (RBD), the rate of overall silent infection and that of HCW's in COVID-19 ward were estimated to be 6.0% and 21.1%, respectively. CONCLUSIONS: For the prevention of nosocomial infection of SARS-CoV-2, identification of silent infection is essential. For the detection of ongoing infection, periodical screening with IgG (RBD) in addition to PCR would be an effective measure. For the surveillance of morbidity in the population, on the other hand, IgG (N)0.2 could be the most reliable indicator among the three serological tests.


Subject(s)
COVID-19 Serological Testing , COVID-19 , Cross Infection , Antibodies, Viral , COVID-19/diagnosis , COVID-19/epidemiology , COVID-19 Serological Testing/methods , Cross Infection/diagnosis , Cross Infection/epidemiology , Cross Infection/prevention & control , Humans , Immunoglobulin G , Japan , Pandemics , SARS-CoV-2 , Serologic Tests/methods , Spike Glycoprotein, Coronavirus
11.
Cell Rep Med ; 3(5): 100631, 2022 05 17.
Article in English | MEDLINE | ID: mdl-35545084

ABSTRACT

Two doses of Pfizer/BioNTech BNT162b2 mRNA vaccine elicit robust severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing antibodies with frequent adverse events. Here, by applying a high-dimensional immune profiling on 92 vaccinees, we identify six vaccine-induced immune dynamics that correlate with the amounts of neutralizing antibodies, the severity of adverse events, or both. The early dynamics of natural killer (NK)/monocyte subsets (CD16+ NK cells, CD56high NK cells, and non-classical monocytes), dendritic cell (DC) subsets (DC3s and CD11c- Axl+ Siglec-6+ [AS]-DCs), and NKT-like cells are revealed as the distinct cell correlates for neutralizing-antibody titers, severity of adverse events, and both, respectively. The cell correlates for neutralizing antibodies or adverse events are consistently associated with elevation of interferon gamma (IFN-γ)-inducible chemokines, but the chemokine receptors CCR2 and CXCR3 are expressed in distinct manners between the two correlates: vaccine-induced expression on the neutralizing-antibody correlate and constitutive expression on the adverse-event correlate. The finding may guide vaccine strategies that balance immunogenicity and reactogenicity.


Subject(s)
BNT162 Vaccine , COVID-19 , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , BNT162 Vaccine/adverse effects , BNT162 Vaccine/immunology , BNT162 Vaccine/therapeutic use , COVID-19/immunology , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , COVID-19 Vaccines/immunology , COVID-19 Vaccines/therapeutic use , Humans , SARS-CoV-2/genetics , Vaccines, Synthetic/adverse effects , Vaccines, Synthetic/immunology , Vaccines, Synthetic/therapeutic use , mRNA Vaccines/adverse effects , mRNA Vaccines/immunology , mRNA Vaccines/therapeutic use
12.
Respirol Case Rep ; 9(10): e0848, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34557304

ABSTRACT

A 65-year-old woman was brought to the emergency unit with an approximately 6-month history of persistent fever and cough. Chest computed tomography (CT) demonstrated a 16-cm heterogeneous mass with adjacent large cyst (approximately 4.0 cm). The patient underwent CT-guided biopsy, and benign solitary fibrous tumour (SFT) was immunohistochemically diagnosed. As the symptoms were thought to be due to enlargement of the tumour, surgery was deemed necessary, and the tumour was successfully resected. Based on morphological and immunohistochemical examination of the resected specimen, the final diagnosis was dedifferentiated SFT (DSFT). Follow-up CT verified disappearance of the pulmonary cyst. The cyst was speculated to be caused by a check valve mechanism, which may also suggest a rapid growth of the tumour. At the time of writing, 2 years post-operatively, no tumour recurrence has been identified. This represents the first report of intrathoracic giant DSFT with a cystic lesion returning to normal lung parenchyma.

13.
Neuroreport ; 17(14): 1525-9, 2006 Oct 02.
Article in English | MEDLINE | ID: mdl-16957602

ABSTRACT

Xylazine, an alpha-2 adrenergic agonist, activates the endogenous trophic factors and neuronal survival signaling. Here, we tested the regenerative effect of xylazine on damaged optic nerve axons in adult rats. After optic nerve crush, xylazine was intraperitoneally injected into three groups of rats: a single administration immediately after the crush, intermittent administration, and daily administration. On day 14, the regenerated axons were quantitatively evaluated by anterograde labeling. Everyday administration but neither single nor intermittent administration markedly increased the number of labeled axons beyond the crush site, with upregulation of growth-associated protein-43 in the ganglion cell layer and the regenerated axons. It was concluded that xylazine promotes axonal regeneration in damaged optic nerves of adult rats.


Subject(s)
Adrenergic alpha-Agonists/therapeutic use , Axons/drug effects , Nerve Regeneration/drug effects , Optic Nerve Injuries/drug therapy , Xylazine/therapeutic use , Animals , Axons/physiology , Cholera Toxin , Drug Administration Schedule , GAP-43 Protein/metabolism , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry/methods , Male , Optic Nerve Injuries/pathology , Rats , Rats, Wistar , Retina/pathology , Retina/physiopathology , Retinal Ganglion Cells/pathology , Up-Regulation/drug effects
14.
Free Radic Res ; 40(6): 589-95, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16753836

ABSTRACT

Both extracellular superoxide dismutase (EC-SOD) and heparin binding EGF like growth factor (HB-EGF) are produced in smooth muscle cells of the arterial wall, and are thought to play pathological roles in atherosclerosis with heparin binding characteristics. EC-SOD treatment clearly reduced the H2O2 induced expression of HB-EGF in rat aortic smooth muscle cells (RASMC). EC-SOD also inhibited the induction of HB-EGF by 12-O-tetradecanoylphorbol-13-acetate (TPA) in RASMC by 60%. Both H2O2 and TPA increased intracellular ROS levels, and EC-SOD inhibited ROS generation only for the case of H2O2 but not TPA. Treatment of the cells with heparin alone decreased HB-EGF expression by 20%, whereas EC-SOD alone and a co-incubation with EC-SOD and heparin suppressed the induction by 60 and 70%, respectively. These results suggest that EC-SOD is related to the EGF signaling in two ways, competition for HSPG with HB-EGF and as an ROS scavenger.


Subject(s)
Aorta/cytology , Epidermal Growth Factor/genetics , Extracellular Space/metabolism , Gene Expression Regulation/drug effects , Muscle, Smooth, Vascular/cytology , Myocytes, Smooth Muscle/drug effects , Superoxide Dismutase/pharmacology , Animals , Cells, Cultured , Heparin/pharmacology , Heparin-binding EGF-like Growth Factor , Intercellular Signaling Peptides and Proteins , Intracellular Space/metabolism , Mice , Myocytes, Smooth Muscle/metabolism , Rats , Reactive Oxygen Species/metabolism , Recombinant Proteins/pharmacology , Superoxide Dismutase/metabolism
17.
Retin Cases Brief Rep ; 2(3): 193-5, 2008.
Article in English | MEDLINE | ID: mdl-25390083

ABSTRACT

PURPOSE: To report electrophysiological and psychophysical findings in an unusual case with acute loss of the peripheral visual field bilaterally. METHODS: A 19-year-old woman underwent fundus photography, fluorescein angiography, visual field testing, determination of full-field electroretinograms (ERGs) and multifocal ERGs (mfERGs), and rod-cone perimetry in addition to routine ophthalmologic examinations. RESULTS: Findings of fundus examination and fluorescein angiography were completely normal, and best-corrected visual acuity was 1.0 in both eyes. However, static perimetry revealed a temporal field defect in the right eye and an arcuate scotoma in the left eye. Full-field ERG cone responses were significantly reduced, but rod responses were normal in both eyes. Psychophysical rod-cone perimetry demonstrated that the peripheral cone system was impaired whereas the rod sensitivity was completely normal. mfERGs showed that the local cone responses were well preserved in the central retina but were severely reduced in the peripheral retina in both eyes. CONCLUSIONS: These results indicate that there is an unusual retinopathy showing acute dysfunction of the peripheral cone system bilaterally whereas the rod system is functioning normally.

18.
Biochem Biophys Res Commun ; 342(1): 127-34, 2006 Mar 31.
Article in English | MEDLINE | ID: mdl-16480686

ABSTRACT

The Long-Evans Cinnamon (LEC) rat, an animal model of Wilson's disease, spontaneously develops hepatitis as the result of abnormal copper accumulation in liver. The findings of this study show that copper, hydrogen peroxide, and lipid peroxides accumulate to drastically high levels in LEC rat serum in acute hepatitis but not chronic hepatitis. The effect of these reactive oxygen species (ROS) on oligosaccharides of glycoproteins in the LEC rat serum was examined. Lectin blot and lectin ELISA analyses showed that sialic acid and galactose residues of serum glycoproteins including transferrin were decreased in acute hepatitis. Further analyses of oligosaccharide structures of transferrin demonstrated that di-sialylated and asialo-agalacto biantennary sugar chains, but not tri-sialylated sugar chain, exist on transferrin in the acute hepatitis rats. In addition, treatment of non-hepatitis rat serum with copper ions and hydrogen peroxide decreased tri-sialylated sugar chain of the normal transferrin and increased di-sialylated and asialo-agalacto biantennary sugar chains. This is the first evidence to show that ROS result in the cleavage of oligosaccharides of glycoproteins in vivo, and indicate this cleavage of oligosaccharides may contribute the development of acute hepatitis.


Subject(s)
Disease Models, Animal , Glycoproteins/chemistry , Glycoproteins/metabolism , Hepatitis, Animal/metabolism , Oligosaccharides/metabolism , Reactive Oxygen Species/metabolism , Acute Disease , Animals , Carbohydrate Conformation , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay , Hepatitis, Animal/congenital , Oligosaccharides/chemistry , Rats , Rats, Inbred LEC , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Transferrin/chemistry , Transferrin/metabolism
19.
Biochem Biophys Res Commun ; 303(3): 914-9, 2003 Apr 11.
Article in English | MEDLINE | ID: mdl-12670498

ABSTRACT

The effect of oxidative stress on the cellular uptake and nuclear translocation of extracellular superoxide dismutase (EC-SOD) was investigated. EC-SOD was incorporated from conditioned medium of stable EC-SOD expressing CHO-EK cells into 3T3-L1 cells within 15 min. The uptake was clearly inhibited by the addition of heparin at a concentration of 0.4 microg/ml. Treatment of the 3T3-L1 cells with H(2)O(2) (5 mM for 5 min), followed by incubation with CHO-EK medium downregulated the uptake of EC-SOD. Nuclear translocation of the incorporated EC-SOD was clearly enhanced by H(2)O(2) treatment following incubation with the CHO-EK medium. EC-SOD is the only anti-oxidant enzyme which is known at this time to be actively transported into nuclei. The results obtained here suggest that the upregulation of the nuclear translocation of EC-SOD by oxidative stress might play a role in the mechanism by which the nucleus is protected against oxidative damage of genomic DNA.


Subject(s)
Oxidative Stress , Superoxide Dismutase/metabolism , 3T3 Cells , Active Transport, Cell Nucleus/drug effects , Animals , Biological Transport, Active/drug effects , CHO Cells , Cricetinae , Culture Media, Conditioned , DNA Damage , Extracellular Space/enzymology , Hydrogen Peroxide/pharmacology , Mice , Reactive Oxygen Species/metabolism , Recombinant Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL